Skip to main content
  •   

    Episode 423: Angiogenesis 2024 Recap with Dr. Philip Rosenfeld Including Discussion of Imaging for AMD, Geographic Atrophy Treatment Benefits and Risks, and More

    Straight from the Cutter’s Mouth
    33:25
    Diagnostic & Imaging , Macular Disease, Retina/Vitreous
    Add to My Bookmarks

    Dr. Philip Rosenfeld joins to discuss the Angiogenesis 2024 meeting, with topics covered including imaging breakthroughs for age-related macular degeneration, geographic atrophy treatment benefits and risks, and the importance of molarity in assessing efficacy and safety of intravitreal agents.

    Relevant Financial Disclosures:
    Dr. Rosenfeld has consulted for Apellis, Regeneron and Zeiss. Dr. Sridhar has consulted for Apellis, Genentech, Iveric, and Regeneron.